Verobioscience
Vero Bioscience measures biological age at the organ level using advanced proteomics and machine learning. Its OrganAge test analyzes thousands of proteins from a single blood draw to detect the earliest molecular signs of organ-specific aging, enabling targeted interventions to slow or reverse the aging process. The company is a Khosla Ventures-backed longevity and diagnostics startup whose work has been published in Nature and Nature Medicine. As of this enrichment pass Vero Bioscience operates a consumer waitlist and partnership program and exposes no public developer API, documentation portal, or SDK surface.
Verobioscience is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Proteomics, Longevity, and Aging.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Company 1
The organization behind the API